Insulin inhalation (Baxter Healthcare)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameInsulin inhalation (Baxter Healthcare)
Drug Alias Name重组人胰岛素吸入粉末（RHIIP）RHIIPRecombinant human insulin inhalation powder (RHIIP)PROMAXX insulin inhalation
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant hormone
Mechanisms of ActionInsulin receptor agonists
TargetsInsulin receptor
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBaxter International Inc
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A